EDINBURGH, Scotland, Feb. 15,
2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC
BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage
biotechnology company developing platform allogeneic gamma-delta T
cell therapies for cancer and other indications, today announced
that CEO, Bryan Kobel and Process
Development Manager, Dr. Lauren Bor
will be featured "Expert Speakers" at the 7th 7th
CAR-TCR Summit Europe, February
27-29th in London,
UK.
Cell therapy industry experts will unite in for the only cell
therapy conference looking in-depth at boosting clinical
durability, advancing predictive biomarkers, and implementing
safety switches through to automating production and accelerating
analytical processes to reduce operational costs and turnaround
times; and new cell therapy technology.
The 7th CAR-TCR Summit Europe provides exclusive access to the
most cutting-edge advances across pre-clinical platforms, clinical
advances, and streamlined manufacturing. The summit is your
must-attend forum to stay at the forefront of cell therapy
innovations. For more information or to register click
here; https://cartcr-europe.com/
About TC BioPharm (Holdings) PLC
TC BioPharm is a clinical-stage biopharmaceutical company
focused on the discovery, development and commercialization of
gamma-delta T cell therapies for the treatment of cancer with human
efficacy data in acute myeloid leukemia. Gamma-delta T cells are
naturally occurring immune cells that embody properties of both the
innate and adaptive immune systems and can intrinsically
differentiate between healthy and diseased tissue.
TC BioPharm is the leader in developing gamma-delta T cell
therapies, and the first company to conduct phase II/pivotal
clinical studies in oncology. The Company is conducting two
investigator-initiated clinical trials for its unmodified
gamma-delta T cell product line - Phase 2b/3 pivotal trial for OmnImmune® in treatment of
acute myeloid leukemia using the Company's proprietary allogeneic
CryoTC technology to provide frozen product to clinics
worldwide.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/tc-biopharm-management-to-participate-at-upcoming-7th-car-tcr-summit-europe-302061638.html
SOURCE TC BioPharm